Sign In

Pablo Fenton

Senior Specialist, Investor Relations and Corporate Communications at Alnylam Pharmaceuticals

Pablo Fenton serves as a Senior Specialist in Investor Relations and Corporate Communications at Alnylam Pharmaceuticals, a leading biotechnology company focused on developing RNA interference (RNAi) therapeutics. His role involves managing communications with investors and the public, ensuring that stakeholders are informed about the company's developments and strategic initiatives.

Fenton has a background in corporate communications and investor relations, having previously held the position of Corporate Communications Manager at Alnylam Pharmaceuticals. His expertise contributes to the company's efforts in maintaining transparency and fostering relationships with investors, which is crucial for a biotech firm navigating the complexities of drug development and market dynamics.34

Alnylam Pharmaceuticals has made significant strides in the field of RNA therapeutics, with several FDA-approved products under its belt, including patisiran and givosiran. The company's focus on innovative drug delivery systems has positioned it as a pioneer in this rapidly evolving area of medicine.12

Highlights

Press Releases | Alnylam Pharmaceuticals
Targeting materials and strategies for RNA delivery - PMC
Alnylam Announces New Management Appointments
Lipid Nanoparticle Delivery Systems to Enable mRNA-Based ...

Related Questions

What are Pablo Fenton's main responsibilities at Alnylam Pharmaceuticals?
How long has Pablo Fenton been with Alnylam Pharmaceuticals?
What is Pablo Fenton's background before joining Alnylam Pharmaceuticals?
What are some notable projects Pablo Fenton has worked on at Alnylam Pharmaceuticals?
How has Pablo Fenton contributed to Alnylam's investor relations and corporate communications?
Pablo Fenton
Pablo Fenton, photo 1
Pablo Fenton, photo 2
Add to my network

Location

Cambridge, Massachusetts